Literature DB >> 28211947

Insulin-like growth factor-1 promotes osteogenic differentiation and collagen I alpha 2 synthesis via induction of mRNA-binding protein LARP6 expression.

Yue Guo1, Chen-Yi Tang1, Xiao-Fei Man1, Hao-Neng Tang1, Jun Tang1, Ci-La Zhou1, Shu-Wen Tan1, Min Wang2, Yun-Zhi Feng3, Hou-De Zhou1.   

Abstract

This study explored the mechanism underlying the stimulation of collagen synthesis and osteoblastic differentiation by insulin-like growth factor 1 (IGF1) in primary mouse osteoblasts. Primary mouse calvarial osteoblasts were cultured and treated with various doses of IGF1 before transfection with siRNA targeting the collagen type I alpha 2 (Col1a2) or La ribonucleoprotein domain family member 6 (Larp6) genes. Alkaline phosphatase (ALP) activity, osteocalcin staining, alizarin red quantification and the expression level of runt-related transcription factor 2 (RUNX2) were performed to assess the differentiation of pre-osteoblasts. Based on Western blot analysis, IGF1 up-regulated COL1A2 protein expression in the primary osteoblasts in a dose- and time-dependent manner. In addition, Col1a2 interference inhibited the differentiation and mineralization of osteoblasts. IGF1 also stimulated the differentiation of mouse primary osteoblasts and increased LARP6 expression during osteogenic differentiation. RNA-Immunoprecipitation (IP) indicated that LARP6 could bind to Col1a2 mRNA after IGF1 stimulation. However, transfection of Larp6-specific siRNA significantly reduced collagen and ALP secretion, mineralization and inhibited the expression of osteocalcin and RUNX2, indicating that Larp6 interference inhibited the differentiation ability of primary mouse calvarial osteoblasts, and these effects could not be reversed by IGF1. Thus, IGF1 could promote COL1A2 expression and osteoblast differentiation in primary mouse calvarial pre-osteoblasts by increasing LARP6 expression via a posttranscriptional mechanism.
© 2017 Japanese Society of Developmental Biologists.

Entities:  

Keywords:  COL1A2; La ribonucleoprotein domain family member 6; insulin-like growth factor 1; osteoblast; osteogenic differentiation

Mesh:

Substances:

Year:  2017        PMID: 28211947     DOI: 10.1111/dgd.12342

Source DB:  PubMed          Journal:  Dev Growth Differ        ISSN: 0012-1592            Impact factor:   2.053


  6 in total

1.  CREB Ameliorates Osteoarthritis Progression Through Regulating Chondrocytes Autophagy via the miR-373/METTL3/TFEB Axis.

Authors:  Haibin Zhang; Xilei Li; Yusheng Li; Xucheng Yang; Runzhi Liao; Haoyi Wang; Junxiao Yang
Journal:  Front Cell Dev Biol       Date:  2022-06-09

Review 2.  The Role of Insulin-Like Growth Factor 1 in the Progression of Age-Related Hearing Loss.

Authors:  Lourdes Rodríguez-de la Rosa; Luis Lassaletta; Miryam Calvino; Silvia Murillo-Cuesta; Isabel Varela-Nieto
Journal:  Front Aging Neurosci       Date:  2017-12-12       Impact factor: 5.750

3.  Calvarial osteoblast gene expression in patients with craniosynostosis leads to novel polygenic mouse model.

Authors:  Jonas A Gustafson; Sarah S Park; Michael L Cunningham
Journal:  PLoS One       Date:  2019-08-23       Impact factor: 3.240

4.  Gene expression profiles and bioinformatics analysis of insulin-like growth factor-1 promotion of osteogenic differentiation.

Authors:  Yashuai Yuan; Ruimeng Duan; Baolin Wu; Wei Huang; Xiuzhi Zhang; Mingjia Qu; Tao Liu; Xiaobing Yu
Journal:  Mol Genet Genomic Med       Date:  2019-08-16       Impact factor: 2.183

5.  Spheroid co-culture of BMSCs with osteocytes yields ring-shaped bone-like tissue that enhances alveolar bone regeneration.

Authors:  Ying-Hui Zhou; Yue Guo; Jia-Yu Zhu; Chen-Yi Tang; Ya-Qiong Zhao; Hou-De Zhou
Journal:  Sci Rep       Date:  2022-08-27       Impact factor: 4.996

6.  Methylation of Cdkn1c may be involved in the regulation of tooth development through cell cycle inhibition.

Authors:  Qiulan Li; Yue Guo; Mianfeng Yao; Jun Li; Yingyi Chen; Qiong Liu; Yun Chen; Yuanyuan Zeng; Bin Ji; Yunzhi Feng
Journal:  J Mol Histol       Date:  2018-07-16       Impact factor: 2.611

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.